Hitoshi Terui

Title(s)Postdoctoral Scholar, Dermatology
SchoolSchool of Medicine
Address513 Parnassus Avenue, HSW, #1201B
San Francisco CA 94143
ORCID ORCID Icon0000-0002-7598-2833 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Tohoku University, JapanMD03/2011Medicine
    Tohoku University, Graduate School of Medicine, JapanPhD03/2022Dermatology

    Collapse Overview 
    Collapse Websites

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. COVID-19 vaccination-induced Sweet syndrome in a patient with squamous cell carcinoma treated with nivolumab. Eur J Dermatol. 2024 Feb 01; 34(1):98-100. Takahashi T, Fujimura T, Terui H, Asano Y. PMID: 38557470.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. A case of lymphangiectatic variant of giant pilomatricoma with bullous appearance: evaluation through magnetic resonance imaging. J Dermatol. 2024 Mar; 51(3):e79-e80. Kobayashi A, Terui H, Takahashi T, Mizuashi M, Asano Y. PMID: 37804059.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Author reply to antibiotics in SAPHO syndrome. J Dermatol. 2024 Jan; 51(1):e26. Terui H, Segawa Y, Otake E, Omori R, Tsuchiyama K, Kikuchi K, Yamasaki K, Aiba S, Asano Y. PMID: 37641893.
      View in: PubMed   Mentions:    Fields:    
    4. Targeting B cells for treatment of systemic sclerosis. Curr Opin Rheumatol. 2023 11 01; 35(6):317-323. Terui H, Segawa Y, Asano Y. PMID: 37540776.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. Successful treatment of pustulotic arthro-osteitis with amoxicillin: A case report and review of the literature. J Dermatol. 2023 Nov; 50(11):1478-1483. Terui H, Segawa Y, Otake E, Omori R, Tsuchiyama K, Kikuchi K, Yamasaki K, Aiba S, Asano Y. PMID: 37269150.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Olaparib-Induced Purpuric Drug Eruption in a Patient with Castration-Resistant Prostate Cancer. Case Rep Oncol. 2023 Jan-Dec; 16(1):419-421. Sekine M, Terui H, Fujimura T, Asano Y. PMID: 37384205; PMCID: PMC10294207.
      View in: PubMed   Mentions:
    7. Recall phenomenon induced by two different agents, iodinated non-ionic contrast and docetaxel-cisplatin, in a single patient. Eur J Dermatol. 2023 04 01; 33(2):183-185. Terui H, Hagihara T, Shimada M, Asano Y, Mizuashi M. PMID: 37431133.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Biologics for Reducing Cardiovascular Risk in Psoriasis Patients. J Clin Med. 2023 Feb 01; 12(3). Terui H, Asano Y. PMID: 36769825; PMCID: PMC9918118.
      View in: PubMed   Mentions: 2  
    9. Possible Efficacy of Vedolizumab, an Anti-α4β7 Integrin Antibody, in Palmoplantar Pustulosis. Case Rep Dermatol. 2023 Jan-Apr; 15(1):22-25. Terui H, Moroi R, Masamune A, Aiba S, Yamasaki K. PMID: 36726801; PMCID: PMC9885181.
      View in: PubMed   Mentions: 2  
    10. The Antimicrobial Peptide Cathelicidin Exerts Immunomodulatory Effects via Scavenger Receptors. Int J Mol Sci. 2023 Jan 03; 24(1). Amagai R, Takahashi T, Terui H, Fujimura T, Yamasaki K, Aiba S, Asano Y. PMID: 36614313; PMCID: PMC9821026.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Staphylococcus aureus skin colonization promotes SLE-like autoimmune inflammation via neutrophil activation and the IL-23/IL-17 axis. Sci Immunol. 2022 10 28; 7(76):eabm9811. Terui H, Yamasaki K, Wada-Irimada M, Onodera-Amagai M, Hatchome N, Mizuashi M, Yamashita R, Kawabe T, Ishii N, Abe T, Asano Y, Aiba S. PMID: 36306369.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    12. Characterization of rosacea patients in Tohoku area of Japan: Retrospective study of 340 rosacea cases. J Dermatol. 2022 May; 49(5):519-524. Wada-Irimada M, Yamamoto H, Terui H, Omori-Shimada R, Yamazaki E, Kikuchi K, Aiba S, Yamasaki K. PMID: 35174900.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Neutrophil Extracellular Traps as a Possible Pathomechanism of Generalized Acquired Cutis Laxa Associated with IgA-lamda Monoclonal Gammopathy of Undetermined Significance. Acta Derm Venereol. 2021 Sep 03; 101(9):adv00536. Terui H, Yamasaki K, Tamabuchi E, Tsuchiyama K, Aiba S. PMID: 34405241; PMCID: PMC9425565.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    14. Biologics modulate antinuclear antibodies, immunoglobulin E, and eosinophil counts in psoriasis patients. J Dermatol. 2021 Nov; 48(11):1739-1744. Sugiura R, Terui H, Shimada-Omori R, Yamazaki E, Tsuchiyama K, Takahashi T, Aiba S, Yamasaki K. PMID: 34368997.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    15. Body mass index, HbA1c and serum C-reactive protein are predictors of secondary failure in infliximab continuance for Japanese psoriasis patients: A hospital-based retrospective case-control study. J Dermatol. 2021 Nov; 48(11):1719-1723. Terui H, Asano M, Shimada-Omori R, Tsuchiyama K, Takahashi T, Nasu-Tamabuchi M, Hagiwara-Takita A, Kusakari Y, Ohtani T, Aiba S, Yamasaki K. PMID: 34355429.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Optimization of the IL-2 Luc assay for immunosuppressive drugs: a novel in vitro immunotoxicity test with high sensitivity and predictivity. Arch Toxicol. 2021 08; 95(8):2755-2768. Kimura Y, Terui H, Fujimura C, Amagai R, Takahashi T, Aiba S. PMID: 34175962.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    17. Chronological changes of skin eruptions toward cold abscess formation in hyper-immunoglobulin E syndrome. J Dermatol. 2021 Jul; 48(7):e316-e317. Fukui R, Hidaka T, Terui H, Rikiishi T, Sasahara Y, Kagimoto Y, Kusakari Y, Yamasaki K, Aiba S. PMID: 33960444.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Pediatric psoriasis induced by HLA-B46-Cw1 haplotype: A retrospective study of psoriasis onset after hematopoietic stem cell transplantation. J Dermatol. 2021 Sep; 48(9):1381-1385. Terui H, Yamasaki K, Hagiwara-Takita A, Shimada-Omori R, Tsuchiyama K, Saito-Nanjo Y, Rikiishi T, Sasahara Y, Aiba S. PMID: 33960525.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. Effect of interleukin-17A inhibitor in Japanese patients with psoriatic arthritis compared with tumor necrosis factor-alpha inhibitor. J Orthop Surg (Hong Kong). 2021 May-Aug; 29(2):23094990211012286. Izumiyama T, Mori Y, Oizumi I, Hamada S, Kurishima H, Terui H, Omori-Shimada R, Yamasaki K, Itoi E. PMID: 33938296.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. The IL-1 promoter-driven luciferase reporter cell line THP-G1b can efficiently predict skin-sensitising chemicals. Arch Toxicol. 2021 05; 95(5):1647-1657. Terui H, Kimura Y, Fujimura C, Aiba S. PMID: 33715048.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    21. Costello syndrome model mice with a HrasG12S/+ mutation are susceptible to develop house dust mite-induced atopic dermatitis. Cell Death Dis. 2020 08 13; 11(8):617. Katata Y, Inoue SI, Asao A, Kobayashi S, Terui H, Inoue-Shibui A, Abe T, Niihori T, Aiba S, Ishii N, Kure S, Aoki Y. PMID: 32792500; PMCID: PMC7426869.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    22. Psoriatic arthritis with skin lesions localized to the scalp: A case report. J Gen Fam Med. 2020 Nov; 21(6):264-267. Akaishi T, Yamasaki K, Mori Y, Takahashi T, Izumiyama T, Terui H, Abe M, Takayama S, Aiba S, Ishii T. PMID: 33304723; PMCID: PMC7689237.
      View in: PubMed   Mentions: 1  
    23. Subcutaneous granulomatous reaction with eosinophil infiltration to a silicone continuous ambulatory peritoneal dialysis Tenckhoff catheter. Contact Dermatitis. 2020 Feb; 82(2):114-116. Hatchome N, Shido K, Kikuchi K, Terui H, Oba-Yabana I, Mori T, Yamasaki K, Aiba S. PMID: 31515810.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: A case report and review of published cases. J Dermatol. 2019 Sep; 46(9):802-807. Takahashi T, Yamasaki K, Terui H, Omori R, Tsuchiyama K, Fujimura T, Aiba S. PMID: 31271451.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    25. Profiling the immunotoxicity of chemicals based on in vitro evaluation by a combination of the Multi-ImmunoTox assay and the IL-8 Luc assay. Arch Toxicol. 2018 06; 92(6):2043-2054. Kimura Y, Fujimura C, Ito Y, Takahashi T, Terui H, Aiba S. PMID: 29594315.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    26. Efficacy of oral cholecalciferol on rhododendrol-induced vitiligo: A blinded randomized clinical trial. J Dermatol. 2018 Apr; 45(4):456-462. Watabe A, Yamasaki K, Asano M, Kanbayashi Y, Nasu-Tamabuchi M, Terui H, Furudate S, Kakizaki A, Tsuchiyama K, Kimura Y, Ito Y, Kikuchi K, Aiba S. PMID: 29399865.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    27. Primary Cutaneous Aggressive Epidermotropic CD8+ T-cell Lymphoma with Brain Involvement and Mimicking Dermatomyositis. Acta Derm Venereol. 2018 01 12; 98(1):128-129. Terui H, Yamasaki K, Yoshida S, Aiba S. PMID: 28597026.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    28. Milia En Plaque as a Distinct Follicular Hamartoma With Cystic Trichoepitheliomatous Features. Am J Dermatopathol. 2016 Mar; 38(3):212-7. Terui H, Hashimoto A, Yamasaki K, Aiba S. PMID: 26381115; PMCID: PMC4760378.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    29. Merkel Cell Carcinoma with Spontaneous Regression: A Case Report and Immunohistochemical Study. Case Rep Dermatol. 2016 Jan-Apr; 8(1):52-8. Terui H, Fujimura T, Kakizaki A, Furudate S, Aiba S. PMID: 27293394; PMCID: PMC4899652.
      View in: PubMed   Mentions: 2  
    30. Pott's Puffy Tumor Caused by Chronic Sinusitis Resulting in Sinocutaneous Fistula. JAMA Dermatol. 2015 Nov; 151(11):1261-3. Terui H, Numata I, Takata Y, Ogura M, Aiba S. PMID: 26017578.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    Hitoshi's Networks
    Concepts (181)
    Derived automatically from this person's publications.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department